These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 10229225)

  • 21. The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo.
    Zhang HT; Scott PA; Morbidelli L; Peak S; Moore J; Turley H; Harris AL; Ziche M; Bicknell R
    Br J Cancer; 2000 Jul; 83(1):63-8. PubMed ID: 10883669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188.
    Maes C; Carmeliet P; Moermans K; Stockmans I; Smets N; Collen D; Bouillon R; Carmeliet G
    Mech Dev; 2002 Feb; 111(1-2):61-73. PubMed ID: 11804779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
    Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The biology of VEGF and its receptors.
    Ferrara N; Gerber HP; LeCouter J
    Nat Med; 2003 Jun; 9(6):669-76. PubMed ID: 12778165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector.
    Byun J; Heard JM; Huh JE; Park SJ; Jung EA; Jeong JO; Gwon HC; Kim DK
    J Mol Cell Cardiol; 2001 Feb; 33(2):295-305. PubMed ID: 11162134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation between expression of TNF alpha, iNOS, VEGF mRNA and development of heart failure after experimental myocardial infarction in rats.
    Heba G; Krzemiński T; Porc M; Grzyb J; Dembińska-Kieć A
    J Physiol Pharmacol; 2001 Mar; 52(1):39-52. PubMed ID: 11321512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of VEGF receptors in adrenal atrophy induced by dexamethasone: a protective role of ACTH.
    Mallet C; Feraud O; Ouengue-Mbele G; Gaillard I; Sappay N; Vittet D; Vilgrain I
    Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E156-67. PubMed ID: 12485811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121.
    Lee LY; Patel SR; Hackett NR; Mack CA; Polce DR; El-Sawy T; Hachamovitch R; Zanzonico P; Sanborn TA; Parikh M; Isom OW; Crystal RG; Rosengart TK
    Ann Thorac Surg; 2000 Jan; 69(1):14-23; discussion 23-4. PubMed ID: 10654479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121.
    Patel SR; Lee LY; Mack CA; Polce DR; El-Sawy T; Hackett NR; Ilercil A; Jones EC; Hahn RT; Isom OW; Rosengart TK; Crystal RG
    Hum Gene Ther; 1999 May; 10(8):1331-48. PubMed ID: 10365664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The VEGF splice variants: properties, receptors, and usage for the treatment of ischemic diseases.
    Poltorak Z; Cohen T; Neufeld G
    Herz; 2000 Mar; 25(2):126-9. PubMed ID: 10829252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesis.
    Lu Y; Shansky J; Del Tatto M; Ferland P; Wang X; Vandenburgh H
    Circulation; 2001 Jul; 104(5):594-9. PubMed ID: 11479259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiogenesis for treatment of ischemic heart disease: should we worry about progression of atherosclerosis?
    Moussa I; Moses JW
    Circulation; 1999 Nov; 100(22):e109. PubMed ID: 10578010
    [No Abstract]   [Full Text] [Related]  

  • 33. Angiogenesis for revascularization of ischaemic tissues.
    Isner JM
    Eur Heart J; 1997 Jan; 18(1):1-2. PubMed ID: 9049503
    [No Abstract]   [Full Text] [Related]  

  • 34. Catheter-based myocardial gene transfer for therapeutic angiogenesis in patient with chronic myocardial ischemia.
    Surawicz B
    Cardiol Rev; 2002; 10(1):2-3. PubMed ID: 11858142
    [No Abstract]   [Full Text] [Related]  

  • 35. [Development of new therapeutics based on the concept "death and regeneration"].
    Morishita R; Ogihara T
    Nihon Ronen Igakkai Zasshi; 2000 Mar; 37(3):198-201. PubMed ID: 10879066
    [No Abstract]   [Full Text] [Related]  

  • 36. Vascular growth factor and gene therapy to induce new vessels in the ischemic myocardium. Therapeutic angiogenesis.
    Kastrup J; Jørgensen E; Drvota V
    Scand Cardiovasc J; 2001 Oct; 35(5):291-6. PubMed ID: 11771818
    [No Abstract]   [Full Text] [Related]  

  • 37. [Autocrine regulation of angiogenesis].
    Yonekura H
    Seikagaku; 2001 Jan; 73(1):27-31. PubMed ID: 11244738
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic myocardial angiogenesis via vascular endothelial growth factor gene therapy: moving on down the road.
    Patterson C; Runge MS
    Circulation; 2000 Aug; 102(9):940-2. PubMed ID: 10961953
    [No Abstract]   [Full Text] [Related]  

  • 39. Angiogenic gene therapy. A leg to stand on?
    Fox JC; Swain JL
    Circulation; 1996 Dec; 94(12):3065-6. PubMed ID: 8989107
    [No Abstract]   [Full Text] [Related]  

  • 40. Isoforms of vascular endothelial growth factor act in a coordinate fashion To recruit and expand tumor vasculature.
    Grunstein J; Masbad JJ; Hickey R; Giordano F; Johnson RS
    Mol Cell Biol; 2000 Oct; 20(19):7282-91. PubMed ID: 10982845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.